On June 8, 2018, the FDA issued a rule classifying all microneedling devices as Class II. The FDA is defining Microneedling devices as “a device using one or more needles to mechanically puncture and injure skin tissue for aesthetic use. This classification does not include devices intended for transdermal delivery of topical products such as cosmetics, drugs, or biologics.”
